Related Experiment Video
Updated: Apr 7, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Amisulpride and symptomatic bradycardia: a case report.
Li-Chung Huang1, Li-Yen Huang2, Shih-Yen Tseng3
1Department of Psychiatry, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi City, Taiwan; Chia Nan University of Pharmacy and Science, Tainan, Taiwan.
This case report details a patient experiencing symptomatic bradycardia while taking amisulpride, an antipsychotic. The condition resolved after discontinuing amisulpride, highlighting a potential rare side effect.
Area of Science:
- Pharmacology
- Clinical Psychiatry
- Cardiology
Background:
- Amisulpride is a second-generation antipsychotic for schizophrenia.
- Bradycardia is a rare, poorly understood side effect of amisulpride.
- Only two prior cases of asymptomatic bradycardia linked to amisulpride exist.
Observation:
- A 45-year-old male developed symptomatic bradycardia during amisulpride treatment (400-800 mg/day).
- Bradycardia symptoms significantly improved upon complete amisulpride cessation.
- Psychiatric stability was maintained with risperidone (3 mg/day) without bradycardia.
Findings:
- This is the first reported case of symptomatic bradycardia associated with amisulpride.
- The Naranjo scale rated the association between amisulpride and bradycardia as "probable".
Implications:
- This case alerts clinicians to the potential for symptomatic bradycardia as an adverse effect of amisulpride.
- Further research is necessary to elucidate the mechanisms by which antipsychotics may induce symptomatic bradycardia.
- Physicians should monitor for bradycardia in patients prescribed amisulpride, particularly those with risk factors.
Related Concept Videos
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Dysrhythmias II: Classification of Tachyarrhythmias

